Krish Patel
9PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 27, 2025
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers.Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka
|Mar 23, 2025
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.Nitin Jain, Toby A Eyre, Katherine B Winfree
|Feb 06, 2024
Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers.Michael L Wang, Jacqueline C Barrientos, Richard R Furman
|Jul 05, 2023
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.Anthony R Mato, Jennifer A Woyach, Jennifer R Brown
|May 16, 2023
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.Michael L Wang, Wojciech Jurczak, Pier Luigi Zinzani
|Feb 03, 2023
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma.Geoffrey Shouse, Andy Kaempf, Max J Gordon
Pageof 2
Frequent Collaborators
2 joint publications
Geoffrey Shouse
2 joint publications
Nirav N Shah
2 joint publications
John F Seymour
2 joint publications
Alvaro J Alencar
2 joint publications
Chan Y Cheah
1 joint publications
Andrea Sitlinger
1 joint publications
Matthew Mei
1 joint publications
Daniel Persky
1 joint publications
Byung Park
1 joint publications
Audrey M Sigmund
